A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

NCT05723562 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Rectal

Interventions

BIOLOGICAL: Dostarlimab

Sponsor

GlaxoSmithKline